Cargando…

Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies

BACKGROUND: Reports have implicated diabetes mellitus (DM) and Alzheimer’s disease (AD) as some of the global persistent health challenges with no lasting solutions, despite of significant inputs of modern-day pharmaceutical firms. This study therefore, aimed to appraise the in vitro antioxidant pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Afolabi, Olakunle Bamikole, Olasehinde, Oluwaseun Ruth, Olanipon, Damilola Grace, Mabayoje, Samson Olatunde, Familua, Olufemi Michael, Jaiyesimi, Kikelomo Folake, Agboola, Esther Kemi, Idowu, Tolulope Olajumoke, Obafemi, Olabisi Tajudeen, Olaoye, Oyindamola Adeniyi, Oloyede, Omotade Ibidun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280950/
https://www.ncbi.nlm.nih.gov/pubmed/37337198
http://dx.doi.org/10.1186/s12906-023-04023-7
_version_ 1785060911512289280
author Afolabi, Olakunle Bamikole
Olasehinde, Oluwaseun Ruth
Olanipon, Damilola Grace
Mabayoje, Samson Olatunde
Familua, Olufemi Michael
Jaiyesimi, Kikelomo Folake
Agboola, Esther Kemi
Idowu, Tolulope Olajumoke
Obafemi, Olabisi Tajudeen
Olaoye, Oyindamola Adeniyi
Oloyede, Omotade Ibidun
author_facet Afolabi, Olakunle Bamikole
Olasehinde, Oluwaseun Ruth
Olanipon, Damilola Grace
Mabayoje, Samson Olatunde
Familua, Olufemi Michael
Jaiyesimi, Kikelomo Folake
Agboola, Esther Kemi
Idowu, Tolulope Olajumoke
Obafemi, Olabisi Tajudeen
Olaoye, Oyindamola Adeniyi
Oloyede, Omotade Ibidun
author_sort Afolabi, Olakunle Bamikole
collection PubMed
description BACKGROUND: Reports have implicated diabetes mellitus (DM) and Alzheimer’s disease (AD) as some of the global persistent health challenges with no lasting solutions, despite of significant inputs of modern-day pharmaceutical firms. This study therefore, aimed to appraise the in vitro antioxidant potential, enzymes inhibitory activities, and as well carry out in silico study on bioactive compounds from polyphenolic-rich extract of Hibiscus cannabinus seed (PEHc). METHODS: In vitro antioxidant assays were performed on PEHc using standard methods while the identification of phytoconstituents was carried out with high performance liquid chromatography (HPLC). For the in silico molecular docking using Schrodinger’s Grid-based ligand docking with energetics software, seven target proteins were retrieved from the database (https://www.rcsb.org/). RESULTS: HPLC technique identified twelve chemical compounds in PEHc, while antioxidant quantification revealed higher total phenolic contents (243.5 ± 0.71 mg GAE/g) than total flavonoid contents (54.06 ± 0.09 mg QE/g) with a significant (p < 0.05) inhibition of ABTS (IC(50) = 218.30 ± 0.87 µg/ml) and 1, 1-diphenyl-2-picrylhydrazyl free radicals (IC(50) = 227.79 ± 0.74 µg/ml). In a similar manner, the extract demonstrated a significant (p < 0.05) inhibitory activity against α-amylase (IC(50) = 256.88 ± 6.15 µg/ml) and α-glucosidase (IC(50) = 183.19 ± 0.23 µg/ml) as well as acetylcholinesterase (IC(50) = 262.95 ± 1.47 µg/ml) and butyrylcholinesterase (IC(50) = 189.97 ± 0.82 µg/ml), respectively. Furthermore, In silico study showed that hibiscetin (a lead) revealed a very strong binding affinity energies for DPP-4, (PDB ID: 1RWQ) and α-amylase (PDB ID: 1SMD), gamma-tocopherol ( for peptide-1 receptor; PDB ID: 3C59, AChE; PDB ID: 4EY7 and BChE; PDB ID: 7B04), cianidanol for α-glucosidase; PDB ID: 7KBJ and kaempferol for Poly [ADP-ribose] polymerase 1 (PARP-1); PDB ID: 6BHV, respectively. More so, ADMET scores revealed drug-like potentials of the lead compounds identified in PEHc. CONCLUSION: As a result, the findings of this study point to potential drug-able compounds in PEHc that could be useful for the management of DM and AD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-023-04023-7.
format Online
Article
Text
id pubmed-10280950
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102809502023-06-21 Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies Afolabi, Olakunle Bamikole Olasehinde, Oluwaseun Ruth Olanipon, Damilola Grace Mabayoje, Samson Olatunde Familua, Olufemi Michael Jaiyesimi, Kikelomo Folake Agboola, Esther Kemi Idowu, Tolulope Olajumoke Obafemi, Olabisi Tajudeen Olaoye, Oyindamola Adeniyi Oloyede, Omotade Ibidun BMC Complement Med Ther Research BACKGROUND: Reports have implicated diabetes mellitus (DM) and Alzheimer’s disease (AD) as some of the global persistent health challenges with no lasting solutions, despite of significant inputs of modern-day pharmaceutical firms. This study therefore, aimed to appraise the in vitro antioxidant potential, enzymes inhibitory activities, and as well carry out in silico study on bioactive compounds from polyphenolic-rich extract of Hibiscus cannabinus seed (PEHc). METHODS: In vitro antioxidant assays were performed on PEHc using standard methods while the identification of phytoconstituents was carried out with high performance liquid chromatography (HPLC). For the in silico molecular docking using Schrodinger’s Grid-based ligand docking with energetics software, seven target proteins were retrieved from the database (https://www.rcsb.org/). RESULTS: HPLC technique identified twelve chemical compounds in PEHc, while antioxidant quantification revealed higher total phenolic contents (243.5 ± 0.71 mg GAE/g) than total flavonoid contents (54.06 ± 0.09 mg QE/g) with a significant (p < 0.05) inhibition of ABTS (IC(50) = 218.30 ± 0.87 µg/ml) and 1, 1-diphenyl-2-picrylhydrazyl free radicals (IC(50) = 227.79 ± 0.74 µg/ml). In a similar manner, the extract demonstrated a significant (p < 0.05) inhibitory activity against α-amylase (IC(50) = 256.88 ± 6.15 µg/ml) and α-glucosidase (IC(50) = 183.19 ± 0.23 µg/ml) as well as acetylcholinesterase (IC(50) = 262.95 ± 1.47 µg/ml) and butyrylcholinesterase (IC(50) = 189.97 ± 0.82 µg/ml), respectively. Furthermore, In silico study showed that hibiscetin (a lead) revealed a very strong binding affinity energies for DPP-4, (PDB ID: 1RWQ) and α-amylase (PDB ID: 1SMD), gamma-tocopherol ( for peptide-1 receptor; PDB ID: 3C59, AChE; PDB ID: 4EY7 and BChE; PDB ID: 7B04), cianidanol for α-glucosidase; PDB ID: 7KBJ and kaempferol for Poly [ADP-ribose] polymerase 1 (PARP-1); PDB ID: 6BHV, respectively. More so, ADMET scores revealed drug-like potentials of the lead compounds identified in PEHc. CONCLUSION: As a result, the findings of this study point to potential drug-able compounds in PEHc that could be useful for the management of DM and AD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-023-04023-7. BioMed Central 2023-06-19 /pmc/articles/PMC10280950/ /pubmed/37337198 http://dx.doi.org/10.1186/s12906-023-04023-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Afolabi, Olakunle Bamikole
Olasehinde, Oluwaseun Ruth
Olanipon, Damilola Grace
Mabayoje, Samson Olatunde
Familua, Olufemi Michael
Jaiyesimi, Kikelomo Folake
Agboola, Esther Kemi
Idowu, Tolulope Olajumoke
Obafemi, Olabisi Tajudeen
Olaoye, Oyindamola Adeniyi
Oloyede, Omotade Ibidun
Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies
title Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies
title_full Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies
title_fullStr Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies
title_full_unstemmed Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies
title_short Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies
title_sort antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of hibiscus cannabinus l. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280950/
https://www.ncbi.nlm.nih.gov/pubmed/37337198
http://dx.doi.org/10.1186/s12906-023-04023-7
work_keys_str_mv AT afolabiolakunlebamikole antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies
AT olasehindeoluwaseunruth antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies
AT olanipondamilolagrace antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies
AT mabayojesamsonolatunde antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies
AT familuaolufemimichael antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies
AT jaiyesimikikelomofolake antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies
AT agboolaestherkemi antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies
AT idowutolulopeolajumoke antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies
AT obafemiolabisitajudeen antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies
AT olaoyeoyindamolaadeniyi antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies
AT oloyedeomotadeibidun antioxidantevaluationandcomputationalpredictionofprospectivedruglikecompoundsfrompolyphenolicrichextractofhibiscuscannabinuslseedasantidiabeticandneuroprotectivetargetsassessmentthroughinvitroandinsilicostudies